Michael J Ajuria, MD
Nephrology · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 5
- Since medical school
- 12 years
- Graduated 2014
Offices
5 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: 552512 · Kaiser Foundation Hospital - Antioch. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ajuria’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A144362 · Current
Licensed to practise in California · since 2016 · expires 2028-02-29 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - AntiochAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.57, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - Antioch
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.57 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 144 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.68 to 1.59) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.4 · 247 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 2,121 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 935 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.09 to 0.52) · 954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.84 (1.25 to 6.42) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4.01) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.09 (0.57 to 3.62) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.89 (0 to 1.98) · 730 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.6 · 38 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.39 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.595 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 83 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.1 · 533 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 55.3 · 30 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 51.9 · 37 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 441 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 149 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,220 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$17,134
Medicare paid this office $17,134 for 120 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $7,919 | $67 |
| Return visit (30+ min) | 31 | $2,150 | $67 |
Who their Medicare patients are
120 Original Medicare patients in 2024. Average age 72 · Under 65 21% · 85 and older 14% · Women 51% · Also on Medicaid 55% · Health risk score 5.31. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Heart failure 63% · Diabetes 59% · Coronary heart disease 47% · Atrial fibrillation 46% · Depression 36% · Dementia 23% · Stroke 21% · Cancer 17% · COPD 15%.
The office billed $54,739, Medicare allowed $24,737 and paid $17,134; for 250 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 120 | 250 | 72 | 5.31 | $54,739 | $17,134 |
| 2023 | 379 | 874 | 74 | 4.96 | $192,098 | $67,603 |
| 2022 | 381 | 964 | 71 | 5.22 | $263,494 | $90,408 |
| 2021 | 471 | 1,144 | 70 | 5.37 | $286,438 | $100,289 |
| 2020 | 205 | 429 | 70 | 4.72 | $103,682 | $39,321 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 219 | $33,303 | $71 |
| Return visit (30+ min) | 70 | $9,119 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,923 | $154 |
| Hemodialysis procedure with physician evaluation | 59 | $5,096 | $65 |
| New patient visit (45+ min) | 19 | $2,911 | $153 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,589 | $118 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,833 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,648 | $103 |
2022: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 215 | $32,771 | $64 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $20,540 | $289 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $14,953 | $176 |
| Return visit (30+ min) | 52 | $6,874 | $83 |
| Hemodialysis procedure with physician evaluation | 56 | $5,061 | $64 |
| New patient visit (45+ min) | 21 | $2,722 | $130 |
| Emergency department visit with high level of medical decision making | 11 | $1,674 | $152 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,087 | $72 |
| Short return visit (20+ min) | 11 | $367 | $31 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 270 | $36,049 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $17,836 | $170 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 37 | $10,867 | $279 |
| Hemodialysis procedure with physician evaluation | 84 | $8,727 | $62 |
| Return visit (30+ min) | 25 | $4,191 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $3,927 | $87 |
| New patient visit (45+ min) | 24 | $3,097 | $129 |
| Short return visit (20+ min) | 34 | $1,886 | $48 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,606 | $89 |
| Short return visit (20+ min) | 13 | $1,388 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $183 | $15 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $12,756 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,864 | $183 |
| Hemodialysis procedure with physician evaluation | 31 | $3,196 | $67 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $3,165 | $264 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,116 | $97 |
| New patient visit (45+ min) | 18 | $2,621 | $146 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $976 | $42 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $861 | $72 |
Medicaid work
$79,910 in 2024
Medicaid paid $79,910 for 254 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 130 | $65,645 |
| Return visit (30+ min) | 86 | $13,032 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 38 | $1,233 |
| 2024 | 254 | 3 | 18 | $79,910 |
| 2023 | 808 | 4 | 29 | $44,539 |
| 2022 | 504 | 5 | 43 | $29,216 |
| 2021 | 600 | 6 | 33 | $14,118 |
| 2020 | 163 | 3 | 18 | $3,702 |
| 2018 | 14 | 1 | 14 | $571 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 186 | $24,313 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 378 | $14,463 |
| Short return visit (20+ min) | 195 | $4,313 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 49 | $1,451 |
2022
| Clinic visit/encounter, all-inclusive | 104 | $13,868 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 67 | $6,374 |
| Short return visit (20+ min) | 159 | $5,702 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 156 | $3,038 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 18 | $235 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 430 | $6,490 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 12 | $2,254 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 23 | $2,182 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 83 | $1,797 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $1,394 |
| Short return visit (20+ min) | 25 | $0 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 124 | $2,771 |
| 1ST HOSP IP/OBS HIGH 75 | 16 | $683 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 23 | $249 |
2018
| Return visit (30+ min) | 14 | $571 |
Drugs they prescribed that Part D paid
$187,428
Pharmacies billed $187,428 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 963) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
734 generic and fewer than 11 brand-name prescriptions · $187,428 in drug cost · 20 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 104 | $55,161 | $530 |
| Farxiga | 38 | $34,037 | $896 |
| Ozempic | 37 | $30,055 | $812 |
| Lokelma | 20 | $12,604 | $630 |
| Sevelamer Carbonate | 31 | $9,371 | $302 |
See all 25 drugs
| Jardiance | 104 | $55,161 | $530 |
| Farxiga | 38 | $34,037 | $896 |
| Ozempic | 37 | $30,055 | $812 |
| Lokelma | 20 | $12,604 | $630 |
| Sevelamer Carbonate | 31 | $9,371 | $302 |
| Calcium Acetate | 11 | $876 | $80 |
| Lidocaine-Prilocaine | 30 | $817 | $27 |
| Bumetanide | 12 | $764 | $64 |
| Furosemide | 46 | $653 | $14 |
| Torsemide | 44 | $583 | $13 |
| Losartan | 63 | $515 | $8 |
| Amlodipine Besylate | 60 | $486 | $8 |
| Chlorthalidone | 32 | $464 | $14 |
| Calcitriol | 18 | $352 | $20 |
| Famotidine | 19 | $349 | $18 |
| Gabapentin | 20 | $342 | $17 |
| Isosorbide Mononitrate Er | 19 | $331 | $17 |
| Lisinopril | 24 | $229 | $10 |
| Spironolactone | 27 | $211 | $8 |
| Nystatin | 11 | $205 | $19 |
| Hydralazine | 12 | $193 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $171 | $16 |
| Clonidine | 12 | $170 | $14 |
| Carvedilol | 12 | $124 | $10 |
| Hydrochlorothiazide | 19 | $115 | $6 |
Year by year
| 2024 | 963 | 264 | 0% (0) | None | $187,428 |
| 2023 | 467 | 123 | 0% (0) | None | $147,863 |
| 2022 | 440 | 105 | 0% (0) | 22% | $125,254 |
| 2021 | 257 | 70 | 0% (0) | 21% | $47,338 |
| 2020 | 50 | 24 | 0% (0) | None | $7,045 |
| 2018 | 82 | 21 | 0% (0) | None | $7,734 |
| 2017 | 36 | None | None | None | $5,786 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Farxiga | 51 | $79,850 | $1,566 |
| Ozempic | 15 | $18,163 | $1,211 |
| Nifedipine Er | 11 | $1,717 | $156 |
| Losartan | 54 | $965 | $18 |
| Hydralazine | 21 | $823 | $39 |
| Torsemide | 25 | $523 | $21 |
| Amlodipine Besylate | 49 | $454 | $9 |
| Famotidine | 11 | $431 | $39 |
| Chlorthalidone | 20 | $427 | $21 |
| Spironolactone | 18 | $409 | $23 |
| Calcitriol | 15 | $368 | $25 |
| Atorvastatin | 13 | $223 | $17 |
2022: 12 drugs
| Farxiga | 50 | $60,409 | $1,208 |
| Ozempic | 14 | $14,373 | $1,027 |
| Bumetanide | 20 | $3,171 | $159 |
| Chlorthalidone | 22 | $662 | $30 |
| Hydralazine | 17 | $629 | $37 |
| Losartan | 31 | $516 | $17 |
| Torsemide | 20 | $381 | $19 |
| Carvedilol | 17 | $348 | $20 |
| Amlodipine Besylate | 52 | $311 | $6 |
| Furosemide | 31 | $216 | $7 |
| Atorvastatin | 14 | $185 | $13 |
| Spironolactone | 18 | $118 | $7 |
2021: 9 drugs
| Invokana | 12 | $12,248 | $1,021 |
| Farxiga | 11 | $8,121 | $738 |
| Bumetanide | 13 | $947 | $73 |
| Losartan | 24 | $326 | $14 |
| Amlodipine Besylate | 51 | $280 | $5 |
| Metoprolol | 14 | $202 | $14 |
| Carvedilol | 11 | $134 | $12 |
| Furosemide | 13 | $95 | $7 |
| Lisinopril | 11 | $66 | $6 |
2020: 1 drug
| Amlodipine Besylate | 12 | $94 | $8 |
Money from drug and device companies
$26 in 2022
| 2022 | 1 | 1 | None | $26 |
| 2019 | 1 | 1 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tavneos | $26 | 1 payment
|
See the published payment
| Amgen | Meals · 2022-09-26 | Tavneos | $26 |
See earlier years (2019)
2019: $29
| Gilead Sciences | None | $29 | 1 payment
|
Professional record
- NPI
- 1922425057
- Licence
- CA A144362California A144362: Current · expires 2028-02-29
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2905 Telegraph Ave, Berkeley, CA, 94705
- NPI first listed
- 2014-03-26
- NPI last updated
- 2020-06-06
- NPI record certified
- 2020-06-06
This is when the NPI record was last certified, not a medical board exam.